Company
Enanta Pharmaceuticals
Enanta Pharmaceuticals has 20 drugs tracked on RxWires: 1 in Phase 2/3, 7 in Phase 2, 12 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| zelicapavir | Phase 2/3 | RSV |
| EDP-323 Dose Regimen 1 | Phase 2 | RSV Infection |
| EDP-938 | Phase 2 | RSV Infection |
| EDP-420 / Duration of Treatment - 3 days | Phase 2 | Community Acquired Pneumonia |
| EDP-305 Dose 1 | Phase 2 | Non-Alcoholic Steatohepatitis |
| EDP-938 Dose 1 | Phase 2 | RSV Infection |
| EDP-305 1.5 mg | Phase 2 | Non-Alcoholic Steatohepatitis |
| EDP-235 | Phase 2 | COVID-19 |
| EDP-514 | Phase 1 | Chronic HBV Infection |
| EDP-978 | Phase 1 | Chronic Inducible Urticaria |
| EDP-322 | Phase 1 | MRSA, SSTI |
| EDP-788 | Phase 1 | Safety in Normal Volunteers |
| DEB025 | Phase 1 | Hepatitis C Virus |
| Fluconazole | Phase 1 | NASH - Nonalcoholic Steatohepatitis |
| EDP-323 | Phase 1 | RSV Infection |
| EDP-494 | Phase 1 | Hepatitis C |
| Midazolam | Phase 1 | NASH |
| intraconazole | Phase 1 | NASH - Nonalcoholic Steatohepatitis |
| EDP239 | Phase 1 | Hepatitis C |
| EDP-721 | Phase 1 | Chronic Hepatitis B Virus Infection |
Latest
- Edp 305 moved to Phase 2
- enanta pharmaceuticals filed 8-K
- enanta pharmaceuticals filed 8-K
- enanta pharmaceuticals filed 8-K
- enanta pharmaceuticals filed 8-K
Follow Enanta Pharmaceuticals on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.